Single-use Bioreactors Market by Product (Single-use Bioreactor, Media Bags, Filtration Assembly, Others), Usage (Lab-scale, Pilot Scale, Large-scale), Type (Stirred tank, Wave-Induced, Bubble-Column, Others), Cell Type (Mammalian, bacterial, Yeast, Others), Application (Bioproduction, Research, Process Development), End user (Pharma & Biotech, CROs, Research and Academia) - Global Forecast to 2025

  • Report ID:MRHC - 104301
  • Pages: 161
  • Jun 2019
  • Formats*: PDF
  • Category: Healthcare

1. Introduction
    1.1. Market Ecosystem
    1.2. Currency & Limitation
           1.2.1. Currency
           1.2.2. Limitation
    1.3. Key Stakeholders

2. Research Methodology
    2.1. Research Process
           2.1.1. Secondary Research
           2.1.2. Primary Research
           2.1.3. Market Size Estimation

3. Executive Summary

4. Market Insights
    4.1. Introduction
    4.2. Drivers
           4.2.1. Rapid Adoption of Disposable Technology in Pharmaceutical and Biotechnology Industry
           4.2.2. Cost Effectiveness and Lower Downtime of Single-use Bioreactor
           4.2.3. Increase in Government Support for Biopharmaceutical Research
           4.2.4. Growing Demand for Biopharmaceuticals
           4.2.5. Frequent Launch of New Products
    4.3. Restraints
           4.3.1. High Expenses Due to Recurrent Demand
           4.3.2. Extractability and Leachability Issues Related to Disposable Components of Bioreactors
           4.3.3. Stringent Regulatory Concerns associated with Single-use Bioreactor
    4.4. Challenge
           4.4.1. Limited Culturing Capacity
    4.5. Opportunities
           4.5.1. Significant Opportunities from Emerging Economies
           4.5.2. Personalized Medicine to Offer New Growth Potential
           4.5.3. Expected Surge in Biosimilar Production in U.S.

5. Single-use Bioreactor Market, by Product
    5.1. Introduction
    5.2. Single use Bioreactor systems
           5.2.1. Upto 10L
           5.2.2. 11L–100L
           5.2.3. 101L–500L
           5.2.4. 501L–1500L
           5.2.5. Above 1500L
    5.3. Media Bags
           5.2.1. 2D Bags
           5.2.2. 3D Bags
           5.2.3. Other Bags
    5.4. Filtration assemblies
    5.5. Others

6. Single-use Bioreactor Market, by Molecule Type
    6.1. Introduction
    6.2. Vaccines
    6.3. Monoclonal Antibodies
    6.4. Stem Cells
    6.5. Recombinant Proteins
    6.6. Drugs
    6.7. Others

7. Single-use Bioreactor Market, by Type
    7.1. Introduction
    7.2. Stirred-Tank
    7.3. Wave-Induced
    7.4. Bubble-Column
    7.5. Others

8. Single-use Bioreactor Market, by Cell type
    8.1. Introduction
    8.2. Mammalian Cells
    8.3. Bacterial Cells
    8.4. Yeast Cells
    8.5. Others

9. Single-use Bioreactor Market, by Application
    9.1. Introduction
    9.2. Bioproduction
    9.3. Research and Development (R&D)
    9.4. Process Development

10. Single-use Bioreactor Market, by Usage
      10.1. Introduction
      10.2. Lab-scale Production
      10.3. Pilot-scale Production
      10.4. Large-scale Production

11. Single-use Bioreactor Market, by End User
      11.1. Introduction
      11.2. Pharmaceutical & Biotechnology Companies
      11.3. Contract Research Organizations (CROs)
      11.4. Research and Academia

12. Single-use Bioreactor Market, by Geography
      12.1. Introduction
      12.2. North America
               12.2.1. U.S.
               12.2.2. Canada
      12.3. Europe
               12.3.1. Germany
               12.3.2. France
               12.3.3. U.K.
               12.3.4. Italy
               12.3.5. Spain
               12.3.6. Rest of Europe
      12.4. Asia-Pacific
               12.4.1. Japan
               12.4.2. China
               12.4.3. India
               12.4.4. Rest of Asia-Pacific
      12.5. Rest of the World
               12.5.1. Latin America
               12.5.2. Middle East & Africa

13. Competitive Landscape
      13.1. Competitive Benchmarking
               13.1.1. By Usage

14. Company Profiles
      14.1. GE Healthcare
      14.2. Merck Group
      14.3. Danaher Corporation
      14.4. Sartorius AG
      14.5. Thermo Fisher Scientific Inc.
      14.6. Eppendorf AG
      14.7. Applikon Biotechnology BV
      14.8. Solaris Biotechnology SRL
      14.9. Cellexus Ltd
      14.10. CESCO Bioengineering Co., Ltd.
      14.11. PBS Biotech, Inc.
      14.12. Pierre Guerin Technologies
      14.13. Distek, Inc.
      14.14. Parker-Hannifin Corporation
      14.15. Celltainer Biotech B.V.
      14.16. Infors AG

15. Appendix 
      15.1. Questionnaire
      15.2. Available Customization

Single-use bioreactor utilizes disposable bag instead of reusable steel vessel used in conventional bioreactors. The use of singleuse bioreactor is influenced by the criticality of the step, fully automated technology, the value of the product produced, and the time taken for product development and production. Owing to the factors such as rapid adoption of disposable technology in pharmaceutical and biotechnology industry, cost effectiveness and lower downtime of single-use bioreactor, increase in government support for biopharmaceutical research, growing demand for biopharmaceuticals, and frequent launch of new products, this industry has witnessed a steady growth.

Furthermore, significant opportunities from emerging economies, demand for personalized medicine, and expected surge in biosimilar production in U.S. is expected to boost the growth of single-use bioreactor market in near future. For instance, according to PharmaManufacturing.com (e-magazine), ~$110 billion of biologics are expected to become off-patent by 2020. Hence, with the growing pressure to reduce the healthcare cost and regulatory clarity on biosimilar, the demand for biosimilars is likely to increase in coming years. Similarly, the increase in number of commercially available personalized medicine in the market from 5 in 2008 to 132 in number in 2016, is boosting the market with the similar trend.

Analysis of Market Segments

The global single-use bioreactor market is segmented by product (single-use bioreactor systems, media bags, filtration assemblies, and others), by molecule type (vaccines, monoclonal antibodies, stem cells, recombinant proteins, drugs, and others), type (stirred-tank, wave-induced, bubble-column, and others), cell type (mammalian, bacterial, yeast, and others), by application (bio production, research, and process development), usage (lab-scale, pilot-scale, large-scale), and end user (pharmaceutical & biotechnology company, contract research organizations research & academia), and geography.

Based on usage, lab-scale production is the most common setting in which single-use bioreactors are preferably used. Lab-scale production commanded the largest share of the global single-use bioreactor market in 2018, owing to simple operation, limited sterilization requirements, and reduced chances of cross-contamination.

Based on application, bio production commanded the largest market share of the global single-use bioreactor market. The high market share of this segment is due to growing demand for breakthrough therapies; increasing government funding; and growing research programs for biopharmaceutical production.

Key Players

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by the leading market participants in the industry over the past 5 years (2015-2018). The key players profiled in the global single-use bioreactor market research report are GE Healthcare, Merck Group, Danaher Corporation, Sartorius AG, Thermo Fisher Scientific Inc., Eppendorf AG, Applikon Biotechnology B.V., Solaris Biotechnology SRL, Cellexus Ltd, CESCO Bioengineering Co., Ltd., PBS Biotech, Inc., Pierre Guerin Technologies, Distek, Inc., Parker-Hannifin Corporation, Celltainer Biotech B.V., and Infors AG.

Future Outlook

Growing adoption of single-use technology since the past decade has been gaining traction at a fast pace and it is expected that most of the biopharmaceutical manufacturers will be having 100% fully disposables facility in operation in the coming years. In these facilities, the major device will be disposable bioreactors, with highest number of installations. Also, these bioreactors will be embedded with improved sensors and higher operational flexibility for multi-drug production within less time. Further, high capacity disposable bioreactors are expected to replace conventional bioreactors in large-scale manufacturing facilities.

Market Segmentation:

Single-use Bioreactors Products

  • Single-use Bioreactor systems
    • Up to 10L
    • 11-100L
    • 101-500L
    • 501-1500L
    • Above 1500L
  • Media bags
  • Filtration Assemblies
  • Others

Single-use Bioreactors Molecules

  • Vaccines
  • Monoclonal Antibodies
  • Stem Cells
  • Recombinant Proteins
  • Drugs
  • Others

Single-use Bioreactors Types

  • Stirred-Tank
  • Wave-Induced
  • Bubble-Column
  • Others

Single-use Bioreactors for Cell Types

  • Mammalian cells
  • Bacterial cells
  • Yeast cells
  • Others

Single-use Bioreactors Applications

  • Bioproduction
  • Research and development
  • Process development

Single-use Bioreactors Usages

  • Lab-scale Production
  • Pilot-scale Production
  • Large-scale Production

Single-use Bioreactors End users

  • Pharmaceutical & Biotechnology companies
  • Contract Research Organizations (CROs)
  • Research and Academia

Single-use Bioreactors Segmentation by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • Middle East & Africa

Key players of the Single-use Bioreactors Market

  • GE Healthcare
  • Merck Group
  • Danaher Corporation
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • Eppendorf AG
  • Applikon Biotechnology B.V.
  • Solaris Biotechnology SRL
  • Cellexus Ltd
  • CESCO Bioengineering Co., Ltd.
  • PBS Biotech, Inc.
  • Pierre Guerin Technologies
  • Distek, Inc.
  • Parker-Hannifin Corporation,
  • Celltainer Biotech B.V.
  • Infors AG.
Report Name
Full Name
Email
Job Title
Company
Country
Phone Number
--
Your Specific Interest
Captcha
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Healthcare
Download Free Sample
+91-744-778-0008